SOMATOSTATIN RECEPTOR

Clinical trials for SOMATOSTATIN RECEPTOR explained in plain language.

Never miss a new study

Get alerted when new SOMATOSTATIN RECEPTOR trials appear

Sign up with your email to follow new studies for SOMATOSTATIN RECEPTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New radioactive drug enters human testing for Hard-to-Treat tumors

Disease control Not yet recruiting

This is the first human study of an experimental radioactive drug called RYZ401 for people with advanced neuroendocrine tumors and other solid tumors that have a specific marker. The main goals are to find the safest and most effective dose, check for side effects, and see if the…

Matched conditions: SOMATOSTATIN RECEPTOR

Phase: PHASE1 • Sponsor: RayzeBio, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

SOMATOSTATIN RECEPTOR

Get alerted when new SOMATOSTATIN RECEPTOR trials appear

New radioactive drug enters human testing for Hard-to-Treat tumors